Patients surviving 5 years after curative oesophagectomy for oesophageal cancer;Patients vivants à 5 ans après cesophagectomie curative pour cancer

Annales de Chirurgie

Volumn 128, Issue 8, 2003, Pages 536-542

  Mariette, C ^a   Fabre, S ^a   Balon, J M ^a   Piessen, G ^a   Lamblin, A ^a   Triboulet, J P ^a  

^a LILLE UNIVERSITY HOSPITAL   (France)

Author keywords

Cancer; Oesophagus; Surgery; Survival

Indexed keywords

ANTINEOPLASTIC AGENT;

ADENOCARCINOMA; ADULT; AGED; ARTICLE; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER RISK; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; DYSPHAGIA; ESOPHAGUS CANCER; ESOPHAGUS RESECTION; FEMALE; HUMAN; HUMAN TISSUE; LONG TERM CARE; LYMPH NODE; MAJOR CLINICAL STUDY; MALE; MALNUTRITION; MULTIVARIATE ANALYSIS; POSTOPERATIVE COMPLICATION; PREOPERATIVE EVALUATION; SQUAMOUS CELL CARCINOMA; SURGICAL MORTALITY; SURGICAL TECHNIQUE; SURVIVAL TIME;

EID: 0142246079     PISSN: 00033944     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0003-3944(03)00192-5     Document Type: Article

References (32)

1. Lightdale CJ. Esophageal cancer. American College of Gastroenterology. Am J Gastro-enterol 1999;94:20-9.
2. Medical Research Council. Surgical resection with or without preoperative chemotherapy in oesophageal cancer: a randomised controlled trial. Lancet 2002;359:1727-33.
3. Hulscher JB, van Sandick JW, de Boer AG, Wijnhoven BP, Tijssen JG, Fockens P, et al. Extended transthoracic resection compared with limited transhiatal resection for adenocarcinoma of the esophagus. N Engl J Med 2002;347:1662-9.
4. Orringer MB, Marshall B, Iannettoni MD. Transhiatal esophagectomy: clinical experience and refinements. Ann Surg 1999;230:392-400.
5. Karl RC, Schreiber R, Boulware D, Baker S, Coppola D. Factors affecting morbidity, mortality, and survival in patients undergoing Ivor Lewis esophagogastrectomy. Ann Surg 2000;231:635-43.
6. Altorki N, Kent M, Ferrara C, Port J. Three-field lymph node dissection for squamous cell and adenocarcinoma of the esophagus. Ann Surg 2002;236:177-83.
7. Osugi H, Takemura M, Takada N, Hirohashi K, Kinoshita H, Higashino M. Prognostic factors after oesophagectomy and extended lymphadenectomy for squamous oesophageal cancer. Br J Surg 2002;89:909-13.
8. Hagen JA, DeMeester SR, Peters JH, Chandrasoma P, DeMeester TR. Curative resection for esophageal adenocarcinoma: analysis of 100 en bloc esophagectomies. Ann Surg 2001;234:520-30.
9. Collard JM, Otte JB, Fiasse R, Laterre PF, De Kock M, Longueville J, et al. Skeletonizing en bloc esophagectomy for cancer. Ann Surg 2001;234:25-32.
10. Birkmeyer JD, Siewers AE, Finlayson EV, Stukel TA, Lucas FL, Batista I, et al. Hospital volume and surgical mortality in the United States. N Engl J Med 2002;346:1128-37.
11. Mariette C, Castel B, Toursel H, Fabre S, Balon JM, Triboulet JP. Surgical management of and long-term survival after adenocarcinoma of the cardia. Br J Surg 2002;89:1156-63.
12. th ed. In: Sobon LH, Wittekind C, editors. UICC TNM Classification of Malignant Tumors. New York: Wiley-Liss; 1997.
13. Mariette C, Balon JM, Piessen G, Fabre S, Van Seuningen I, Triboulet JP. Pattern of recurrence following complete resection of esophageal cancer and factors predictive of recurrent disease. Cancer 2003;97:1616-23.
14. Lerut T, De Leyn P, Coosemans W, Van Raemdonck D, Scheys I, LeSaffre E. Surgical strategies in esophageal carcinoma with emphasis on radical lymphadenectomy. Ann Surg 1992;216:583-90.
15. Holscher AH, Bollschweiler E, Bumm R, Bartels H, Hofler H, Siewert JR. Prognostic factors of resected adenocarcinoma of the esophagus. Surgery 1995;118:845-55.
16. Bhansali MS, Fujita H, Kakegawa T, Yamana H, Ono T, Hikita S, et al. Pattern of recurrence after extended radical esophagectomy with three-field lymph node dissection for squamous cell carcinoma in the thoracic esophagus. World J Surg 1997;21:275-81.
17. Akiyama H, Tsurumaru M, Udagawa H, Kajiyama Y. Radical lymph node dissection for cancer of the thoracic esophagus. Ann Surg 1994;220:364-72.
18. Walsh TN, Noonan N, Hollywood D, Kelly A, Keeling N, Hennessy TP. A comparison of multimodal therapy and surgery for esophageal adenocarcinoma. N Engl J Med 1996;335:462-7.
19. Eloubeidi MA, Desmond R, Arguedas MR, Reed CE, Wilcox CM. Prognostic factors for the survival of patients with esophageal carcinoma in the U.S.: the importance of tumor length and lymph node status. Cancer 2002;95:1434-43.
20. Korst RJ, Rusch VW, Venkatraman E, Bains MS, Burt ME, Downey RJ, et al. Proposed revision of the staging classification for esophageal cancer. J Thorac Cardiovasc Surg 1998;115:660-9.
21. Nigro JJ, DeMeester SR, Hagen JA, DeMeester TR, Peters JH, Kiyabu M, et al. Node status in transmural esophageal adenocarcinoma and outcome after en bloc esophagectomy. J Thorac Cardiovasc Surg 1999;117:960-8.
22. Stewart JR, Hoff SJ, Johnson DH, Murray MJ, Butler DR, Elkins CC, et al. Improved survival with neo-adjuvant therapy and resection for adenocarcinoma of the esophagus. Ann Surg 1993;218:571-6.
23. Bessell JR, Devitt PG, Gill PG. Prolonged survival followsresection of oesophageal SCC downstaged by prior chemoradiotherapy. Aust NZ J Surg 1996;66:214-7.
24. Woronoff AS, Mercier M, Gignoux M, Triboulet JP, Chaillard G, Bosset JF. Facteurs pronostiques des cancers épidermoïdes de l'œsophage opérables. Gastro-enterol Clin Biol 1998;22:168-74.
25. Mariette C, Maurel A, Fabre S, Balon JM, Triboulet JP. Facteurs pronostiques pré-opératoires des cancers épidermoïdes de l'œsophage thoracique. Gastro-enterol Clin Biol 2001;25:468-72.
26. Bosset JF, Gignoux M, Triboulet JP, Tiret E, Mantion G, Elias D, et al. Chemoradiotherapy followed by surgery compared with surgery alone in squamous-cell cancer of the esophagus. N Engl J Med 1997;1337:161-7.
27. Le Prise E, Etienne PL, Meunier B, Maddern G, Ben Hassel M, Gedouin D, et al. A randomized study of chemotherapy, radiation therapy, and surgery versus surgery for localized squamous cell carcinoma of the esophagus. Cancer 1994;73:1779-84.
28. Nygaard K, Hagen S, Hansen HS, Hatlevoll R, Hultborn R, Jakobsen A, et al. Pre-operative radiotherapy prolongs survival in operable esophageal carcinoma: a randomized, multicenter study of preoperative radiotherapy and chemotherapy. The second Scandinavian trial in esophageal cancer. World J Surg 1992;16:1104-9.
29. Apinop C, Puttisak P, Preecha N. A prospective study of combined therapy in esophageal cancer. Hepatogastro-enterology 1994;41:391-3.
30. Urba SG, Orringer MB, Turrisi A, Iannettoni M, Forastiere A, Strawderman M. Randomized trial of preoperative chemoradiation versus surgery alone in patients with locoregional esophageal carcinoma. J Clin Oncol 2001;19:305-13.
31. Pouliquen X, Levard H, Hay JM, McGee K, Fingerhut A, Langlois-Zantin O. 5-Fluorouracil and cisplatin therapy after palliative surgical resection of squamous cell carcinoma of the esophagus. A multicenter randomized trial. French Associations for Surgical Research. Ann Surg 1996;223:127-33.
32. Ando N, Iizuka T, Kakegawa T, Isono K, Watanabe H, Ide H, et al. A randomized trial of surgery with and without chemotherapy for localized squamous carcinoma of the thoracic esophagus: the Japan Clinical Oncology Group Study. J Thorac Cardiovasc Surg 1997;114:205-9.